In a pre-clinical model of melanoma, platelet activation caused effective release of anti-PDL1 by platelet-derived microparticles and prolonged survival after surgery by reducing the risk of cancer regrowth and metastatic spread [24, 25]. This evidence concerns the gene CD274 and melanoma.